[go: up one dir, main page]

IN2013MU02208A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02208A
IN2013MU02208A IN2208MU2013A IN2013MU02208A IN 2013MU02208 A IN2013MU02208 A IN 2013MU02208A IN 2208MU2013 A IN2208MU2013 A IN 2208MU2013A IN 2013MU02208 A IN2013MU02208 A IN 2013MU02208A
Authority
IN
India
Prior art keywords
fixed dose
relates
antiflatulents
pharmaceutical compositions
present
Prior art date
Application number
Inventor
Vijay Patil
Ragini Singh
Venugopal PRABHAKARAN
Shajahan Mohamed MUSTHABA
Selvaraj SEKAR
Stefanie Krenzlin
Original Assignee
Abbott India Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott India Ltd filed Critical Abbott India Ltd
Priority to IN2208MU2013 priority Critical patent/IN2013MU02208A/en
Publication of IN2013MU02208A publication Critical patent/IN2013MU02208A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to fixed dose combination of mebeverine and one or more antiflatulents. The present invention further relates to pharmaceutical compositions comprising fixed dose combination of modified release mebeverine hydrochloride and antiflatulents. The invention also relates to methods of preparing such fixed dose combinations and pharmaceutical compositions.
IN2208MU2013 2013-06-29 2013-06-29 IN2013MU02208A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2208MU2013 IN2013MU02208A (en) 2013-06-29 2013-06-29

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2208MU2013 IN2013MU02208A (en) 2013-06-29 2013-06-29

Publications (1)

Publication Number Publication Date
IN2013MU02208A true IN2013MU02208A (en) 2015-06-12

Family

ID=54396464

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2208MU2013 IN2013MU02208A (en) 2013-06-29 2013-06-29

Country Status (1)

Country Link
IN (1) IN2013MU02208A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023152674A1 (en) 2022-02-09 2023-08-17 Berlia Sushma Paul A pharmaceutical combination of antispasmodic and anxiolytic agent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023152674A1 (en) 2022-02-09 2023-08-17 Berlia Sushma Paul A pharmaceutical combination of antispasmodic and anxiolytic agent

Similar Documents

Publication Publication Date Title
IL283760A (en) Compositions comprising dextromethorphan and bupropion or related compounds and uses thereof
IL283152A (en) High dose tetracyclic compound containing compositions methods of producing same and uses thereof
MX2015008999A (en) Mk2 inhibitors and uses thereof.
ZA201505011B (en) Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
IL246252A0 (en) Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
IN2015DN00127A (en)
MX2021011906A (en) Delayed release compositions of linaclotide.
MX2020001756A (en) Benzoquinolone inhibitors of vmat2.
SG10201902326XA (en) Mk2 inhibitors and uses thereof
PH12019500176B1 (en) Heterocyclic compounds and ther uses
PL3065732T3 (en) Compounds, compositions and uses thereof for the prevention and/or treatment of dyslipidemia
MX2020004205A (en) Ceftolozane antibiotic compositions.
IL251120A0 (en) Immunogenic/therapeutic glycoconjugate compositions and uses thereof
IN2013MU03641A (en)
PH12017500348B1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
MX368870B (en) Use of an opioid receptor antagonist with kappa-activity and vortioxetine for treatment of depressive disorder with melancholic features.
AU2016356504A8 (en) 5-hydroxytryptamine 1B receptor-stimulating agent for enhancing in vivo engraftment potential
PL3209828T3 (en) N-halamine containing fibrous compositions and uses thereof
GEP20217236B (en) Composition comprising pentose and polyphenolic compound
NZ721832A (en) Solid forms of tenofovir
IN2013MU02208A (en)
MX375355B (en) Compositions and methods for treating intracerebral hemorrhage
SG11201608538UA (en) Compounds compositions and methods including thermally labile moieties
ZA201807210B (en) Use of sugar-alcohols in tibolone compositions
IN2013CH05770A (en)